Ad
related to: sarcopenia epidemiology
Search results
Results from the WOW.Com Content Network
Sarcopenia (ICD-10-CM code M62.84 [1]) is a type of muscle loss that occurs with aging and/or immobility. It is characterized by the degenerative loss of skeletal muscle mass, quality, and strength. The rate of muscle loss is dependent on exercise level, co-morbidities, nutrition and other factors.
Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD) is an international and multidisciplinary non-profit organization, created in 2008 that focuses on cachexia [1] and sarcopenia. [2] As they are often under-diagnosed, patient groups aim to improve their awareness. [ 3 ]
The Journal of Cachexia, Sarcopenia and Muscle is a quarterly peer-reviewed medical journal that covers research relevant to changes in body composition, especially cachexia and sarcopenia, as consequences of chronic illnesses or of the aging process, respectively.
Sarcopenia is the degenerative loss of skeletal muscle mass, quality, and strength associated with aging. [19] The rate of muscle loss is dependent on exercise level, co-existing health conditions, nutrition and other factors. Sarcopenia can lead to reduction in functional status and cause significant disability from increased muscle weakness.
Sarcopenic obesity is a combination of two disease states, sarcopenia and obesity. Sarcopenia is the muscle mass/strength/physical function loss associated with increased age, [ 1 ] and obesity is based off a weight to height ratio or body mass index (BMI) that is characterized by high body fat or being overweight.
These contributions include advancements in the knowledge of the role of dietary calcium [7] [8] and vitamin D in promoting nutrition and bone health, [9] the role of nutrients in maintaining the optimal immune response [10] and prevention of infectious diseases, role of diet in prevention of cancer, obesity research, [11] modifications to the ...
Clinically, cachexia can be difficult to define due to its frequent concurrence with malnutrition and sarcopenia. [12] Due to the absence of specific criteria distinguishing sarcopenia, malnutrition, and cachexia, recent efforts have looked to reach consensus definitions to improve efforts in countering nutritional abnormalities.
Manuscripts are published on the biology and physiology of bone and muscle, relevant systems biology topics (e.g. osteoimmunology), and the pathophysiology and treatment of osteoporosis, sarcopenia and other disorders of bone and mineral metabolism.
Ad
related to: sarcopenia epidemiology